Samantha Wright
Pain Medicine · Arlington, VANPI 1275201501
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Medtronic at 31.6% of the total. Reporting peaked in 2024 at $1,964 and has fallen 68.1% since, to $627 in 2025.
Across 142 payments — averaging $35.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AbbVie$583
- Vertos Medical, Inc.$530
- Boston Scientific$446
- MML US, Inc.$286
- Collegium Pharmaceutical, Inc.$243
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 34 | $1,580 |
| AbbVie | 19 | $583 |
| Vertos Medical, Inc. | 8 | $530 |
| Boston Scientific | 15 | $446 |
| MML US, Inc. | 7 | $286 |
| Collegium Pharmaceutical, Inc. | 17 | $243 |
| Sanofi | 6 | $220 |
| Relievant Medsystems, Inc. | 2 | $170 |
| Vertex | 2 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $108 |
| Spine Wave, Inc. | 1 | $104 |
| Nevro Corp. | 3 | $94 |
| Pfizer | 4 | $88 |
| Si-bone, Inc. | 2 | $60 |
| Scilex Pharmaceuticals Inc. | 3 | $59 |
| Fidia Pharma USA Inc. | 2 | $40 |
| Biotronik NRO, Inc. | 2 | $39 |
| Averitas Pharma Inc. | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Globus Medical | 1 | $31 |
| Stryker | 1 | $24 |
| IBSA Pharma Inc. | 1 | $24 |
| Spinal Simplicity, LLC | 1 | $23 |
| Almatica Pharma LLC | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$602
- mild Device Kit$366
- INTELLIS ADAPTIVESTIM$313
- ReActiv8$146
- SYNCHROMEDII$125
- DUPIXENT$124
- SPINAL IMPLANT$104
How this compares
$4,999 in reported general payments places this provider in the 75th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 16 | $15,731 |
| OxycontinOxycodone Hcl | 25 | $13,377 |
| MovantikNaloxegol Oxalate | 14 | $9,038 |
| Lidocaine | 39 | $8,881 |
| Buprenorphine | 18 | $6,133 |
| Tramadol Hcl ErTramadol Hcl | 32 | $3,698 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 176 | $2,928 |
| Duloxetine Hcl | 41 | $2,313 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 122 | $2,281 |
| Diclofenac Sodium | 35 | $1,747 |
| Oxycodone Hcl | 130 | $1,626 |
| Gabapentin | 82 | $1,406 |
| Tizanidine Hcl | 47 | $1,010 |
| Pregabalin | 36 | $878 |
| Naloxone Hcl | 16 | $834 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $88 | $15,73116 claims |
| Hikma Pharmaceuticals USABuprenorphine | $20 | $6,13318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 150 pain medicine providers in Virginia.
Other pain medicine in Arlington
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- George BaylorSalem$24K
- Jasmit BrarLansdowne$18K
- Christina ShinCharlottesville$18K
- Michael DepalmaRichmond$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.